Exscientia IPO Presentation Deck
September 2021, 60 slides
  1. Exscientia
  2. Related Decks
  3. IPO Presentation Decks
better drugs faster | Exscientia
offering summary | Exscientia
forward looking statements | Exscientia
better drugs faster all | Exscientia
| Exscientia
sea | Exscientia
| Exscientia
| Exscientia
outstanding efficiency in drug discovery i | Exscientia
foundations for transforming an industry | Exscientia
tech with sophistication | Exscientia
rapidly scaling pipeline doing more to learn more | Exscientia
| Exscientia
patient first is a process be or | Exscientia
| Exscientia
high content patient tissue imaging platform | Exscientia
| Exscientia
first platform demonstrated to improve clinical outcomes | Exscientia
| Exscientia
precision objectives for precision design on | Exscientia
rot a | Exscientia
| Exscientia
| Exscientia
active learning leads to creative breakthroughs | Exscientia
technology in action case study exs | Exscientia
| Exscientia
precision design to effectiveness | Exscientia
design flaws can impact clinical outcomes | Exscientia
our exs candidate resolves critical design issues | Exscientia
highly effective in classical models | Exscientia
sparing immune cells in comparison to i | Exscientia
i defining patient selection during drug design | Exscientia
| Exscientia
| Exscientia
appendix | Exscientia
we need a better way discover new drugs | Exscientia
gates foundation pandemic preparedness | Exscientia
pandemic threat is accelerating | Exscientia
gates foundation collaboration expanding to antivirals | Exscientia
technology in action | Exscientia
complex immune target requiring balanced profile | Exscientia
a | Exscientia
agog antagonist exs equivalent efficacy to | Exscientia
pharmacological profile versus competition | Exscientia
| Exscientia
technology in action | Exscientia
kinase large failures on an attractive target | Exscientia
| Exscientia
technology in action case study | Exscientia
| Exscientia
delivering multiple candidates | Exscientia
technology appendix | Exscientia
a | Exscientia
designing every molecule using | Exscientia
ing problem | Exscientia
| Exscientia
physics based predictive modelling | Exscientia
our platform is truly data agnostic | Exscientia
| Exscientia
| Exscientia
See More
Exscientia
IPO Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Cancer
Drug discovery
Recent decks by Exscientia
Investor Presentation
March 2024
Results
March 2024
Investor Day
January 2024
Investor Presentation
November 2023
See all presentations by Exscientia (14 decks)
Related decks
Recursion Pharmaceuticals
Investor Day
January 2023
23andMe
Investor Presentation
April 2023
23andMe
Investor Day
January 2022
Absci
Investor Conference
January 2023
AstraZeneca
Results
February 2021
BioNTech
Results
November 2020
Mainz Biomed NV
Investor Presentation
October 2023
RenovoRx
IPO
August 2021
Recent decks by Exscientia
See all presentations (14 decks)
Investor Presentation
March 2024
Results
March 2024
Investor Day
January 2024
Investor Presentation
November 2023
Recursion Pharmaceuticals
Investor Day
January 2023
23andMe
Investor Presentation
April 2023
23andMe
Investor Day
January 2022
Absci
Investor Conference
January 2023
AstraZeneca
Results
February 2021
BioNTech
Results
November 2020
Mainz Biomed NV
Investor Presentation
October 2023
RenovoRx
IPO
August 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io